Will cancer patients with cervical cancer have elevated carcinoembryonic antigen (CEA) levels?
Nov 15, 2023
Source: Cainiu Health
Dr. Zhao Xiaodong
Introduction
In general, carcinoembryonic antigen (CEA) levels in patients with cervical cancer may be elevated or remain normal, and the interpretation should take into account various clinical factors. Cervical cancer is a malignant tumor that arises at the junction of squamous epithelial cells in the vaginal portion of the cervix or transformation zone and columnar epithelial cells of the cervical canal. It is recommended that cervical cancer patients undergo regular follow-up examinations and monitoring.
In general, carcinoembryonic antigen (CEA) levels may increase in patients with cervical cancer, but they may also remain unchanged; a comprehensive evaluation of various factors is required. The specific analysis is as follows:
1. Yes
Cervical cancer is a malignant tumor occurring at the junction of squamous epithelial cells in the vaginal portion of the cervix or transformation zone and columnar epithelial cells of the cervical canal mucosa. CEA levels may rise in patients with cervical cancer, typically due to tumor cells producing and releasing CEA, leading to elevated blood CEA levels. Additionally, the high degree of cellular atypia in cervical cancer cells—marked differences from normal cells—may also contribute to increased CEA levels.
2. No
In some cervical cancer patients, tumor cells may not produce or may produce only small amounts of CEA, so CEA levels do not increase. This may be related to factors such as gene expression patterns, degree of differentiation, and cellular atypia of the tumor cells.
It is recommended that cervical cancer patients undergo regular follow-up examinations and monitoring. A comprehensive assessment combining multiple diagnostic methods and clinical manifestations should be performed to provide accurate and effective treatment plans for patients.
